Ono Pharmaceutical Co., Ltd.
OPHLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,232,759 | $138,991,000 | $204,567,000 | $160,982,000 |
| Short-Term Investments | $5,864 | $165,000 | $5,813,000 | $9,858,000 |
| Receivables | $941,253 | $143,540,000 | $135,022,000 | $152,211,000 |
| Inventory | $468,260 | $70,765,000 | $74,864,000 | $77,621,000 |
| Other Curr. Assets | $198,829 | $33,218,000 | $34,838,000 | $31,254,000 |
| Total Curr. Assets | $2,846,965 | $386,679,000 | $455,104,000 | $431,926,000 |
| Property Plant & Equip (Net) | $695,169 | $103,736,000 | $105,721,000 | $106,733,000 |
| Goodwill | $142,838 | $20,519,000 | $21,186,000 | $22,413,000 |
| Intangibles | $2,450,391 | $360,084,000 | $330,041,000 | $354,792,000 |
| Long-Term Investments | $658,164 | $89,706,000 | $88,558,000 | $110,937,000 |
| Tax Assets | $342,553 | $0 | $51,020,000 | $0 |
| Other NC Assets | $31,296 | $62,865,000 | $12,416,000 | $55,503,000 |
| Total NC Assets | $4,320,412 | $636,910,000 | $608,942,000 | $650,378,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,167,377 | $1,023,589,000 | $1,064,046,000 | $1,082,304,000 |
| Liabilities | – | – | – | – |
| Payables | $442,272 | $63,147,000 | $89,329,000 | $61,124,000 |
| Short-Term Debt | $222,311 | $30,000,000 | $30,000,000 | $30,000,000 |
| Tax Payable | $0 | $0 | $4,058,000 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $154,606 | $33,447,000 | $21,731,000 | $27,709,000 |
| Total Curr. Liab. | $951,667 | $129,456,000 | $148,296,000 | $121,838,000 |
| LT Debt | $609,405 | $97,500,000 | $105,000,000 | $112,500,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $34,668 | $0 | $10,817,000 | $0 |
| Other NC Liab. | $22,115 | $10,542,000 | $3,231,000 | $17,690,000 |
| Total NC Liab. | $717,534 | $115,791,000 | $127,548,000 | $138,971,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $10,611,000 | $11,678,000 | $11,786,000 |
| Total Liabilities | $1,669,201 | $245,247,000 | $275,844,000 | $260,809,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $117,534 | $17,358,000 | $17,358,000 | $17,358,000 |
| Retained Earnings | $5,515,387 | $789,980,000 | $790,908,000 | $791,609,000 |
| AOCI | $133,812 | $28,363,000 | $19,790,000 | $70,047,000 |
| Other Equity | $7 | $0 | $0 | $0 |
| Total Equity | $5,459,932 | $772,638,000 | $782,451,000 | $815,918,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $38,250 | $5,704,000 | $5,751,000 | $5,577,000 |
| Total Liab. & Tot. Equity | $7,167,383 | $1,023,589,000 | $1,064,046,000 | $1,082,304,000 |
| Net Debt | -$401,043 | -$11,491,000 | -$69,567,000 | -$18,482,000 |